5-Methylcytosine (m
5-Methylcytosine
biomarker
colorectal cancer
diagnosis
peripheral blood
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
13
06
2022
accepted:
02
09
2022
entrez:
10
10
2022
pubmed:
11
10
2022
medline:
12
10
2022
Statut:
epublish
Résumé
Current non-invasive tumor biomarkers failed to accurately identify patients with colorectal cancer (CRC), delaying CRC diagnosis and thus leading to poor prognosis. Dysregulation of 5-Methylcytosine (m
Identifiants
pubmed: 36211353
doi: 10.3389/fimmu.2022.967921
pmc: PMC9532581
doi:
Substances chimiques
Biomarkers, Tumor
0
MicroRNAs
0
5-Methylcytosine
6R795CQT4H
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
967921Informations de copyright
Copyright © 2022 Yin, Huang, Niu, Ming, Jiang, Gu, Huang, Xie, He and Zhang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor GW declared a shared parent affiliation with the authors HY, ZH, SN, LM, HJ, LG, WH, YH, CZ at the time of review.
Références
Mol Cell. 2019 Sep 19;75(6):1188-1202.e11
pubmed: 31399345
Nature. 2022 Jun;606(7914):576-584
pubmed: 35385861
Cancer Manag Res. 2020 Jun 22;12:4789-4797
pubmed: 32606968
Blood. 2020 Sep 10;136(11):1330-1341
pubmed: 32678428
Theranostics. 2021 Jan 1;11(5):2201-2217
pubmed: 33500720
Sci Rep. 2020 Sep 28;10(1):15934
pubmed: 32985589
Gut. 2022 Jul;71(7):1315-1325
pubmed: 34462336
Nat Genet. 2017 Apr;49(4):635-642
pubmed: 28263317
Gut. 2016 Jun;65(6):990-1000
pubmed: 25814648
Gut. 2015 Oct;64(10):1637-49
pubmed: 26041752
Nat Cell Biol. 2019 Aug;21(8):978-990
pubmed: 31358969
Theranostics. 2017 Jul 8;7(11):2878-2887
pubmed: 28824722
Cancer Manag Res. 2021 Oct 20;13:7989-8002
pubmed: 34707405
Cell Commun Signal. 2018 Apr 24;16(1):17
pubmed: 29690889
Gastroenterology. 2020 Jan;158(2):341-353
pubmed: 31394082
Biomark Res. 2022 Apr 1;10(1):15
pubmed: 35365216
Oncoimmunology. 2017 Oct 11;7(2):e1380765
pubmed: 29416940
Ann Intern Med. 2021 Sep;174(9):1224-1231
pubmed: 34280333
Front Cell Dev Biol. 2021 May 17;9:658101
pubmed: 34079797
Cell Death Dis. 2020 Apr 24;11(4):270
pubmed: 32332707
Cancer Res. 2019 Apr 1;79(7):1285-1292
pubmed: 30894375
EBioMedicine. 2021 Dec;74:103706
pubmed: 34801967
J Cell Physiol. 2019 Aug;234(8):12422-12432
pubmed: 30637729
Front Immunol. 2021 Mar 10;12:641507
pubmed: 33777035
Gastroenterology. 2020 Jan;158(2):418-432
pubmed: 31394083
Prz Gastroenterol. 2019;14(2):89-103
pubmed: 31616522
Nat Rev Mol Cell Biol. 2019 Oct;20(10):573-589
pubmed: 31270442
Oncogenesis. 2016 Jan 18;5:e187
pubmed: 26779809
Am J Transl Res. 2020 Jul 15;12(7):3858-3870
pubmed: 32774740
Cancer Res. 2016 Jun 15;76(12):3446-50
pubmed: 27256564
Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):13012-13022
pubmed: 32444490
Cell Metab. 2020 Sep 1;32(3):498-499
pubmed: 32877692
Nat Methods. 2015 Mar;12(3):230-2, 1 p following 232
pubmed: 25362363
Cell Res. 2017 May;27(5):606-625
pubmed: 28418038
Gastroenterology. 2018 May;154(7):1970-1984
pubmed: 29454795
Gastroenterology. 2017 Jul;153(1):307-323
pubmed: 28600072
Nature. 2021 Feb;590(7847):635-641
pubmed: 33429418
Nat Commun. 2018 Mar 21;9(1):1163
pubmed: 29563491
J Gene Med. 2020 Aug;22(8):e3189
pubmed: 32196834
Science. 2019 Jun 07;364(6444):
pubmed: 31171663
EBioMedicine. 2021 Jan;63:103195
pubmed: 33418496
Clin Cancer Res. 2021 Sep 1;27(17):4669-4679
pubmed: 33827891
Clin Transl Med. 2020 Dec;10(8):e249
pubmed: 33377655
Front Immunol. 2021 Sep 30;12:760747
pubmed: 34659267
Front Cell Dev Biol. 2021 Apr 13;9:657547
pubmed: 33928086
Mol Oncol. 2017 Jul;11(7):824-846
pubmed: 28614624
Br J Cancer. 2015 Jul 14;113(2):268-74
pubmed: 26035703
Br J Cancer. 2017 Feb 28;116(5):658-668
pubmed: 28141796